From: Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults
Characteristic | Men (n = 1898) | Women (n = 2095) | P value | Total (n = 3993) |
---|---|---|---|---|
Age (years) | 50.80 (16.76) | 50.20 (16.05) | 0.25 | 50.49 (16.39) |
Weight (kg) | 85.32 (15.98) | 72.25 (15.74) | <0.0001 | 78.46 (17.38) |
Waist girth (cm) | 98.43 (13.03) | 87.09 (14.12) | <0.0001 | 92.47 (14.74) |
BMI (kg/m2) | 27.89 (4.78) | 27.75 (6.04) | 0.41 | 27.82 (5.48) |
Overweight (BMI 25.00 – 29.99 kg/m2)1 | 874 (46.05%) | 663 (31.65%) | <0.0001 | 1537 (38.49%) |
Obese (BMI ≥ 30 kg/m2)1 | 512 (26.98%) | 632 (30.17%) | 0.03 | 1144 (28.65%) |
Glucose (mmol/L)2 | 5.1 (4.8-5.6) | 4.9 (4.5-5.3) | <0.0001 | 5.00 (4.6-5.5) |
Triglycerides (mmol/L)2 | 1.3 (0.9-2.0) | 1.1 (0.8-1.6) | <0.0001 | 1.20 (0.9-1.8) |
HDL cholesterol (mmol/L)2 | 1.2 (1.0-1.4) | 1.5 (1.2-1.7) | <0.0001 | 1.30 (1.1-1.6) |
Total cholesterol (mmol/L)2 | 5.1 (4.4-5.8) | 5.2 (4.6-6.0) | 0.0001 | 5.2 (4.5-5.9) |
Systolic blood pressure (mmHg) | 130.90 (17.61) | 125.50 (19.15) | <0.0001 | 128.03 (18.63) |
Diastolic blood pressure (mmHg) | 82.65 (9.96) | 78.79 (10.04) | <0.0001 | 80.63 (10.19) |
Mean arteriole pressure (mmHg) | 98.72 (11.20) | 94.35 (11.89) | <0.0001 | 96.43 (11.77) |
Metabolic syndrome (ATPIII)1 | 553 (29.14%) | 461 (22.00%) | <0.0001 | 1014 (25.39%) |
Type 2 diabetes1 | 218 (11.49%) | 170 (8.11%) | 0.0003 | 388 (9.72%) |
Cardiovascular disease1 | 199 (10.48%) | 120 (5.73%) | <0.0001 | 319 (7.99%) |
Cardiometabolic disease1 | 363 (19.13%) | 251 (11.98%) | <0.0001 | 614 (15.38%) |